Table 2.
Retrospective comparisons of myeloablative versus RIC allo-HSCT
ABL indicates ablative regimen; URD, unrelated donor; MRD, matched related donor.
*P value not significant.
†Cumulative incidence for all patients; no difference according to conditioning regimen.
